trial · primary record
TheraSphere Y-90 glass microsphere therapy
Hepatocellular Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-06 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT05063565 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:20.434Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05063565
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.